Hospital Italiano de Cordoba

Córdoba X5004FJE

1 studies enrolling now · 12 studies all time

What they study most

Atrial Fibrillation, Cardiovascular Diseases, Chemotherapy-Induced Nausea and Vomiting, Chronic Obstructive Pulmonary Disease, Coagulopathy, Congestive Heart Failure, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Hypertension, Hypertension, Pulmonary, Lung Diseases, Lupus Erythematosus, Systemic

Studies at this site

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients — Completed
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension — Enrolling by invitation
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus — Stopped early
A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus — Completed
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH) — Stopped early
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) — Stopped early
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy — Completed
A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting — Completed
EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed